Dialysis

Community-acquired AKI is a common entity associated with serious adverse clinical outcomes during the 6-month period after diagnosis, according to a recently published study.

PHILADELPHIA — Tenapanor in combination with sevelamer may control serum phosphate levels in patients with hyperphosphatemia on dialysis, according to data from ASN Kidney Week.

Focal segmental glomerulosclerosis-attributed kidney failure may be linked with significant clinical and economic burdens, according to a recently published study.

The Renal Healthcare Association has appointed William Poirier, MBA, BSN, BA, RN, to serve as new executive director of the renal trade organization, according to a press release.

PHILADELPHIA — The percent of patients who choose home dialysis within the first year of treatment varies by country, a study presented here showed.

PHILADELPHIA — The case of a 29-year-old woman with chronic kidney disease presented at ASN Kidney Week highlighted the need for better health care education to help patients understand the risks and consequences of their disease.

Fresenius Medical Care is recalling millions of single use sterile syringes used during hemodialysis treatments because of leakages, the company reported.

The FDA has approved DefenCath, a catheter lock solution of taurolidine and heparin by CorMedix Inc., for adults with kidney failure on chronic hemodialysis, according to a press release.

PHILADELPHIA — Racial and ethnic differences exist in arteriovenous access use in patients 1 year after hemodialysis initiation, according to data presented at ASN Kidney Week.

PHILADELPHIA — Researchers presented data at ASN Kidney Week from a prediction model that can forecast all-cause mortality in adults with advanced chronic kidney disease.